(NYSE: PFE) Pfizer's forecast annual revenue growth rate of -1.34% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 6.79%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.8%.
Pfizer's revenue in 2025 is $63,833,000,000.On average, 5 Wall Street analysts forecast PFE's revenue for 2025 to be $362,820,096,167,109, with the lowest PFE revenue forecast at $360,757,105,539,285, and the highest PFE revenue forecast at $364,743,358,705,845. On average, 6 Wall Street analysts forecast PFE's revenue for 2026 to be $357,592,806,722,960, with the lowest PFE revenue forecast at $350,519,873,875,500, and the highest PFE revenue forecast at $365,337,078,002,358.
In 2027, PFE is forecast to generate $347,665,380,705,920 in revenue, with the lowest revenue forecast at $343,408,159,888,080 and the highest revenue forecast at $353,941,301,713,188.